Third Point’s Amgen AMGN Stock Holding History

Third Point’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,000,000	Closed	-$450M	–	41
2016 Q1	$450M	Sell	3,000,000 -6,042,900	-67%	-$898M	4.14%	6
2015 Q4	$1.47B	Sell	9,042,900 -807,100	-8%	-$127M	14.89%	3
2015 Q3	$1.36B	Buy	9,850,000 +850,000	+9%	+$134M	12.85%	2
2015 Q2	$1.38B	Sell	9,000,000 -1,000,000	-10%	-$160M	12.94%	1
2015 Q1	$1.6B	Sell	10,000,000 -675,000	-6%	-$106M	14.77%	1
2014 Q4	$1.7B	Buy	10,675,000 +9,350,000	+706%	+$1.46B	15.34%	1
2014 Q3	$186M	Buy	1,325,000 +875,000	+194%	+$114M	2.14%	19
2014 Q2	$53.3M	Buy	+450,000	New	+$52.1M	0.65%	34

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Third Point's AMGN Position: Q2 2016 in Review

Third Point sold out of Amgen (AMGN) in Q2 2016, closing a stake of 3,000,000 shares — an estimated $450M sold.

Third Point first reported a position in AMGN in Q2 2014 and held it in 8 quarters. The position peaked at $1.7B in Q4 2014. 1,472 funds tracked by Wall St. Rank hold AMGN as of Q2 2016.

Third Point reported no remaining Amgen position as of Q2 2016 after selling out during the quarter.
Third Point sold 3,000,000 Amgen shares in Q2 2016, an estimated $450M.
Third Point first reported a position in Amgen in Q2 2014 and held it in 8 quarters.
Third Point's Amgen position peaked at $1.7B in Q4 2014.
1,472 funds tracked by Wall St. Rank held Amgen as of Q2 2016.

Based on Third Point's 13F filing for Q2 2016, filed 12 Aug 2016.